Stocks · News reference

8-K filing — Alector, Inc. (ALEC)

2026-10-16 20:47:14 UTCSEC EDGAR

Filed: 2026-10-16 AccNo: 0001193125-26-424204 Size: 423 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ALEC

Source: edgar
Observed: 2026-10-16 20:47:14 UTC
Checked: 2026-10-16 20:47:14 UTC
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

Fiscal.ai2026-11-06 14:03:45 UTC
Alector Reports Third Quarter 2026 Financial Results
Alector, Inc. reported its third-quarter 2026 financial results, highlighting a net income of $124.6 million driven by the recognition of deferred revenue following the termination of its agreement with GSK.
ALEC
Benzinga2026-10-16 11:32:11 UTCBenzinga Newsdesk
Alector Prices $75.03M Common Stock Offering Of 36.6M Shares At $2.05/Share
ALEC
Benzinga2026-10-15 12:31:09 UTCAvi Kapoor
Fastenal To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday
Analysts raised targets for TSM, MRNA, ALEC and WMT; cut AZZ, ARRY and ALGN targets, upgrading ARRY/WMT and downgrading ALGN.
ALEC ALGN ARRY AZZ FAST
Benzinga2026-10-15 10:57:01 UTCBenzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8
HC Wainwright & Co. analyst Andrew S. Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $5 to $8.
ALEC
Benzinga2026-10-06 17:01:56 UTCBenzinga Newsdesk
Morgan Stanley Maintains Underweight on Alector, Raises Price Target to $3
Morgan Stanley analyst Sean Laaman maintains Alector (NASDAQ:ALEC) with a Underweight and raises the price target from $2 to $3.
ALEC
Benzinga2026-10-05 16:29:14 UTCBenzinga Newsdesk
Alector shares are trading higher after the company announced an exclusive global licensing agreement granting Genentech worldwide rights to develop and commercialize its AL050 program.
ALEC

8-K filing — Alector, Inc. (ALEC)

Connected Markets

Related Headlines

Alector Reports Third Quarter 2026 Financial Results

Alector Prices $75.03M Common Stock Offering Of 36.6M Shares At $2.05/Share

Fastenal To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday

HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8

Morgan Stanley Maintains Underweight on Alector, Raises Price Target to $3

Alector shares are trading higher after the company announced an exclusive global licensing agreement granting Genentech worldwide rights to develop and commercialize its AL050 program.